Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 98, Issue 10, Pages 1448-1452
Publisher
BMJ
Online
2014-07-18
DOI
10.1136/bjophthalmol-2014-305105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
- (2014) Sylvie Julien et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences
- (2012) Heidrun L Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): Towards slowing the macular ageing process
- (2012) F. Treumer et al. EXPERIMENTAL EYE RESEARCH
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION
- (2012) Raul Velez-Montoya et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- THE EFFECTS OF AFLIBERCEPT ON THE VIABILITY AND METABOLISM OF OCULAR CELLS IN VITRO
- (2012) David A. Ammar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
- (2011) Wiem Lassoued et al. CANCER BIOLOGY & THERAPY
- Defective photoreceptor phagocytosis in a mouse model of enhanced S-cone syndrome causes progressive retinal degeneration
- (2011) Debarshi Mustafi et al. FASEB JOURNAL
- Quantifying FITC-Labeled Latex Beads Opsonized with Photoreceptor Outer Segment Fragments: An Easy and Inexpensive Method of Investigating Phagocytosis in Retinal Pigment Epithelium Cells
- (2011) Alexa Klettner et al. OPHTHALMIC RESEARCH
- Deferoxamine mesylate is toxic for retinal pigment epithelium cellsin vitro, and its toxicity is mediated by p38
- (2010) Alexa Klettner et al. Cutaneous and Ocular Toxicology
- Neovascular age-related macular degeneration: decision making and optimal management
- (2010) S P Harding EYE
- Intracellular bevacizumab reduces phagocytotic uptake in RPE cells
- (2010) Alexa Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
- (2010) Robert Hörster et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- SAFETY TESTING OF INDOCYANINE GREEN WITH DIFFERENT SURGICAL LIGHT SOURCES AND THE PROTECTIVE EFFECT OF OPTICAL FILTERS
- (2010) JOST HILLENKAMP et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
- (2009) S Jyothi et al. EYE
- Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells
- (2009) Alexa Karina Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target
- (2009) A. Klettner et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started